Cargando…

Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk

22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function h...

Descripción completa

Detalles Bibliográficos
Autores principales: Francisco, Ana A., Horsthuis, Douwe J., Popiel, Maryann, Foxe, John J., Molholm, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390764/
https://www.ncbi.nlm.nih.gov/pubmed/32731196
http://dx.doi.org/10.1016/j.nicl.2020.102351
_version_ 1783564508841639936
author Francisco, Ana A.
Horsthuis, Douwe J.
Popiel, Maryann
Foxe, John J.
Molholm, Sophie
author_facet Francisco, Ana A.
Horsthuis, Douwe J.
Popiel, Maryann
Foxe, John J.
Molholm, Sophie
author_sort Francisco, Ana A.
collection PubMed
description 22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function have been noted in this population, but the underlying neural processes are not well understood. Using a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response (a critical component of executive function) in individuals with 22q11.2DS with and without psychotic symptoms, when compared to individuals with idiopathic schizophrenia and age-matched neurotypical controls. Twenty-eight participants diagnosed with 22q11.2DS (14–35 years old; 14 with at least one psychotic symptom), 15 individuals diagnosed with schizophrenia (18–63 years old) and two neurotypical control groups (one age-matched to the 22q11.2DS sample, the other age-matched to the schizophrenia sample) participated in this study. Analyses focused on the N2 and P3 no-go responses and error-related negativity (Ne) and positivity (Pe). Atypical inhibitory processing was shown behaviorally and by significantly reduced P3, Ne, and Pe responses in 22q11.2DS and schizophrenia. Interestingly, whereas P3 was only reduced in the presence of psychotic symptoms, Ne and Pe were equally reduced in schizophrenia and 22q11.2DS, regardless of the presence of symptoms. We argue that while P3 may be a marker of disease severity, Ne and Pe might be candidate markers of risk.
format Online
Article
Text
id pubmed-7390764
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73907642020-08-04 Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk Francisco, Ana A. Horsthuis, Douwe J. Popiel, Maryann Foxe, John J. Molholm, Sophie Neuroimage Clin Regular Article 22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function have been noted in this population, but the underlying neural processes are not well understood. Using a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response (a critical component of executive function) in individuals with 22q11.2DS with and without psychotic symptoms, when compared to individuals with idiopathic schizophrenia and age-matched neurotypical controls. Twenty-eight participants diagnosed with 22q11.2DS (14–35 years old; 14 with at least one psychotic symptom), 15 individuals diagnosed with schizophrenia (18–63 years old) and two neurotypical control groups (one age-matched to the 22q11.2DS sample, the other age-matched to the schizophrenia sample) participated in this study. Analyses focused on the N2 and P3 no-go responses and error-related negativity (Ne) and positivity (Pe). Atypical inhibitory processing was shown behaviorally and by significantly reduced P3, Ne, and Pe responses in 22q11.2DS and schizophrenia. Interestingly, whereas P3 was only reduced in the presence of psychotic symptoms, Ne and Pe were equally reduced in schizophrenia and 22q11.2DS, regardless of the presence of symptoms. We argue that while P3 may be a marker of disease severity, Ne and Pe might be candidate markers of risk. Elsevier 2020-07-17 /pmc/articles/PMC7390764/ /pubmed/32731196 http://dx.doi.org/10.1016/j.nicl.2020.102351 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Francisco, Ana A.
Horsthuis, Douwe J.
Popiel, Maryann
Foxe, John J.
Molholm, Sophie
Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title_full Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title_fullStr Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title_full_unstemmed Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title_short Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk
title_sort atypical response inhibition and error processing in 22q11.2 deletion syndrome and schizophrenia: towards neuromarkers of disease progression and risk
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390764/
https://www.ncbi.nlm.nih.gov/pubmed/32731196
http://dx.doi.org/10.1016/j.nicl.2020.102351
work_keys_str_mv AT franciscoanaa atypicalresponseinhibitionanderrorprocessingin22q112deletionsyndromeandschizophreniatowardsneuromarkersofdiseaseprogressionandrisk
AT horsthuisdouwej atypicalresponseinhibitionanderrorprocessingin22q112deletionsyndromeandschizophreniatowardsneuromarkersofdiseaseprogressionandrisk
AT popielmaryann atypicalresponseinhibitionanderrorprocessingin22q112deletionsyndromeandschizophreniatowardsneuromarkersofdiseaseprogressionandrisk
AT foxejohnj atypicalresponseinhibitionanderrorprocessingin22q112deletionsyndromeandschizophreniatowardsneuromarkersofdiseaseprogressionandrisk
AT molholmsophie atypicalresponseinhibitionanderrorprocessingin22q112deletionsyndromeandschizophreniatowardsneuromarkersofdiseaseprogressionandrisk